https://hub-xchange.com/advanced-therapies-xchange-new-jersey-20262026-08-03T12:43:41Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/registration2026-08-03T11:47:08Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/opening-address-keynote-presentation-improving-reliability-efficiency-in-cell-gene-therapy-manufacturing2026-08-03T11:50:23Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/overcoming-challenges-hindering-potency-within-the-tumour-microenvironment-to-enhance-the-efficacy-of-cell-therapies-for-solid-tumours2026-08-03T11:52:39Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/overcoming-data-driven-challenges-to-minimize-toxicity-in-gene-therapy-development2024-12-02T13:02:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/analytical-testing-strategies-for-gene-therapy-gmp-release-testing-stability-testing-and-comparability-assessments2024-05-22T11:14:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/1-2-1-meetings-/-networking-break2024-05-22T11:19:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/1-2-1-meetings-/-networking-break-12024-05-22T11:20:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/cell-therapy-manufacturing-topic-how-can-workflow-flexibility-influence-cell-therapy-accessibility-and-time-to-market2024-05-22T11:22:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/cell-manufacturing-topic-resolving-process-variability-as-the-primary-barrier-to-scalable-cell-therapy-manufacturing2025-01-29T14:32:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/scaling-cell-therapy-manufacturing-without-compromising-quality-rethinking-compliance-digitalization-and-gmp2025-01-29T14:32:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/networking-lunch2024-05-22T11:42:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/spotlight-presentation-commercial-readiness-for-advanced-therapeutics-strategy-scale-and-execution2024-05-22T11:44:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/1-2-1-meetings-/-networking-break-22024-05-22T11:44:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/1-2-1-meetings-/-networking-break-32024-05-22T11:45:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/poster-presentation-addressing-cell-processing-constraints-with-low-shear-automated-centrifugation2024-05-22T11:54:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/process-robustness-and-product-consistency-in-psc-derived-cell-therapy-development2025-01-20T15:03:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/analytical-method-transfer-robust-assays-reproducibility-and-tech-transfer-pitfalls2025-01-10T14:16:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/evening-drinks-reception2024-05-22T13:20:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/ensuring-consistent-product-quality-a-key-manufacturing-challenge-in-cell-and-gene-therapy-vs-advanced-biologics2026-08-03T11:59:53Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/morning-refreshments2024-07-17T10:09:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/afternoon-refreshments2024-07-17T10:54:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/standardizes-complex-cgt-assays-replaces-variable-primary-cells-with-consistent-controls-for-potency-phenotype-and-transduction-readouts2024-11-05T15:31:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/poster-presentation-accelerating-nextgeneration-cell-therapy-manufacturing-with-scalable-immune-cell-engineering-workflows2025-06-20T21:43:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/addressing-an-important-challenge-faced-how-can-we-enhance-aav-lv-and-non-viral-delivery-technologies-to-increase-efficiency-tissue-targeting-and-reduce-immunogenicity2024-11-26T14:36:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/upstream-strategies-to-reduce-empty-capsid-formation2025-02-27T14:14:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/bridging-next-generation-capsid-innovation-and-manufacturability-aligning-research-and-cmc-for-clinical-readiness2025-11-03T11:36:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/next-generation-gene-therapy-manufacturing-to-drive-better-in-vivo-outcomes-improving-vector-quality-and-delivery-efficiency-to-reduce-dose-requirements-improve-safety-and-achieve-greater-scalability2025-11-03T11:46:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/next-gen-delivery-methods-in-vivo-vs-ex-vivo-approaches-for-autologous-and-allogeneic-therapies2026-04-09T10:43:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/spotlight-presentation-advanced-analytical-solutions-for-gene-therapy-genomic-safety-and-characterization2025-11-17T09:58:00Zhttps://hub-xchange.com/advanced-therapies-xchange-new-jersey-2026/1-2-1-meetings-/-networking-break-42026-04-10T13:46:00Z